Recruiting studies: Cancer Of The Salivary Gland

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143 Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
Phase 2 · 13 location(s) · Dana-Farber Cancer Institute · NCT04620187 A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
Phase 2 · 2 location(s) · Glenn J. Hanna · NCT06805617 The Association Between Bilateral Intermediate Cervical Plexus Block During Total Thyroidectomy and Surgical Stress Resp
Phase 4 · 1 location(s) · University Hospital Dubrava · NCT07600580 DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000 The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: a Single-
Phase 2 · 1 location(s) · Ji Dongmei · NCT07464366 Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Can
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT00900419 Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
EARLY_Phase 1 · 2 location(s) · Brigham and Women's Hospital · NCT05553782 A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Phase 1/Phase 2 · 8 location(s) · LigaChem Biosciences, Inc. · NCT05941507 Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis
NA · 1 location(s) · University of Pavia · NCT07491536 Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Phase N/A · 4 location(s) · Vanderbilt University Medical Center · NCT00898638 FArial NErf MRI in the Preoperative Assessment of PArotide Tumors
Phase N/A · 1 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT04613349 The Study on the Mechanism of Radiotherapy-elicited Immune Response
Phase N/A · 1 location(s) · Fudan University · NCT06393140 Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05884320 Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931 PDO Based Drug Sensitive Test in R/M SGC
Phase N/A · 2 location(s) · Huashan Hospital · NCT06686979 Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objective
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT01365169 Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT03740256 Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzum
Phase 2 · 152 location(s) · NRG Oncology · NCT05408845 DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adul
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05786716 The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
Phase N/A · 10 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT05483374 Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699 Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia
NA · 1 location(s) · University of Rochester · NCT04805528 Swedish National Parotidectomy Study (SNaPs): Drainless Versus Standard Surgery
NA · 3 location(s) · Uppsala University Hospital · NCT07620184 Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)
Phase 2 · 1 location(s) · National University Hospital, Singapore · NCT06923826 Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NI
Phase 1 · 52 location(s) · National Cancer Institute (NCI) · NCT03816345 Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study
NA · 1 location(s) · Universidad de Granada · NCT05106608 VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Phase 1/Phase 2 · 15 location(s) · VM Oncology, LLC · NCT03556228 A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Phase 2 · 28 location(s) · Jazz Pharmaceuticals · NCT06695845 A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
Phase 1 · 9 location(s) · Avacta Life Sciences Ltd · NCT04969835

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.